Smoking modifies the associated increased risk of future cardiovascular disease by genetic variation on chromosome 9p21

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Hamrefors, Viktor ^a,b   Hedblad, Bo ^a   Hindy, George ^a   Smith, J Gustav ^a,b,c   Almgren, Peter ^a   Engström, Gunnar ^a   Sjögren, Marketa ^a   Gränsbo, Klas ^a,b   Orho Melander, Marju ^a   Melander, Olle ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHROMOSOME 9P; CHROMOSOME 9P21; CORONARY ARTERY DISEASE; EDUCATIONAL STATUS; FEMALE; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHYSICAL ACTIVITY; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ADVERSE EFFECTS; AGED; CARDIOVASCULAR DISEASES; CHROMOSOME 9; EPIDEMIOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; MORTALITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; QUESTIONNAIRE; REGISTER; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; SWEDEN;

AGED; CARDIOVASCULAR DISEASES; CHROMOSOMES, HUMAN, PAIR 9; EDUCATIONAL STATUS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; REGISTRIES; RISK FACTORS; SMOKING; SURVIVAL RATE; SWEDEN;

EID: 84899798557     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085893     Document Type: Article

References (27)

1. Lloyd-Jones DM, Nam BH, D'Agostino RB Sr, Levy D, Murabito JM, et al. (2004) Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA 291: 2204-2211. (Pubitemid 38608169)
2. Kathiresan S, Srivastava D (2012) Genetics of human cardiovascular disease. Cell 148: 1242-1257.
3. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43: 333-338.
4. Myocardial Infarction Genetics Consortium, Kathiresan S, Voight BF, Purcell S, Musunuru K, et al. (2009) Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 41: 334-341.
5. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, et al. (2007) A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316: 1491-1493. (Pubitemid 46906618)
6. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, et al. (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316: 1488-1491. (Pubitemid 46906617)
7. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, et al. (2007) Genomewide association analysis of coronary artery disease. N Engl J Med 357: 443-453. (Pubitemid 47204873)
8. Schunkert H, Götz A, Braund P, McGinnis R, Tregouet DA, et al. (2008) Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 117: 1675-1684. (Pubitemid 351482592)
9. Abdullah KG, Li L, Shen GQ, Hu Y, Yang Y, et al. (2008) Four SNPS on chromosome 9p21 confer risk to premature, familial CAD and MI in an American Caucasian population (GeneQuest). Ann Hum Genet 72: 654-657.
10. Hiura Y, Fukushima Y, Yuno M, Sawamura H, Kokubo Y, et al. (2008) Validation of the association of genetic variants on chromosome 9p21 and 1q41 with myocardial infarction in a Japanese population. Circ J 72: 1213-1217.
11. Assimes TL, Knowles JW, Basu A, Iribarren C, Southwick A, et al. (2008) Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum Mol Genet 17: 2320-2328.
12. Anderson CD, Biffi A, Rost NS, Cortellini L, Furie KL, et al. (2010) Chromosome 9p21 in ischemic stroke: population structure and meta-analysis. Stroke 41: 1123-1131.
13. Manolio TA (2009) Cohort studies and the genetics of complex disease. Nat Genet 41: 5-6.
14. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, et al. (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33: 1635-1701.
15. Ordovas JM, Tai ES (2008) Why study gene-environment interactions? Curr Opin Lipidol 19: 158-167. (Pubitemid 351483303)
16. Willett WC (2002) Balancing life-style and genomics research for disease prevention. Science 296: 695-698.
17. Berglund G, Elmstahl S, Janzon L, Larsson SA (1993) The Malmo Diet and Cancer Study. Design and feasibility. J Intern Med 233: 45-51.
18. Engstrom G, Jerntorp I, Pessah-Rasmussen H, Hedblad B, Berglund G, et al. (2001) Geographic distribution of stroke incidence within an urban population: relations to socioeconomic circumstances and prevalence of cardiovascular risk factors. Stroke 32: 1098-1103. (Pubitemid 32825790)
19. The Swedish National Board of Health and Welfare (2000) Evaluation of quality of diagnosis of acute myocardial infarction, inpatient register 1997 and 1995.
20. Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, et al. (2007) Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356: 1009-1019. (Pubitemid 46376801)
21. Khan FA, Zia E, Janzon L, Engstrom G (2004) Incidence of stroke and stroke subtypes in Malmo, Sweden, 1990-2000: marked differences between groups defined by birth country. Stroke 35: 2054-2058. (Pubitemid 39129559)
22. Li C, Aronsson CA, Hedblad B, Gullberg B, Wirfalt E, et al. (2009) Ability of physical activity measurements to assess health-related risks. Eur J Clin Nutr 63: 1448-1451.
23. Folsom AR, Nambi V, Pankow JS, Tang W, Farbakhsh K, et al. (2012) Effect of 9p21 genetic variation on coronary heart disease is not modified by other risk markers. The Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 224: 435-439.
24. Holdt LM, Teupser D (2012) Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arterioscler Thromb Vasc Biol 32: 196-206.
25. Ripatti S, Tikkanen E, Orho-Melander M, Havulinna AS, Silander K, et al. (2010) A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet 376: 1393-1400.
26. Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, et al. (2009) Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med 150: 65-72.
27. Brautbar A, Ballantyne CM, Lawson K, Nambi V, Chambless L, et al. (2009) Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study. Circ Cardiovasc Genet 2: 279-285.